“Repeat-dose toxicity in rats and cynomolgus monkeys have been conducted, 2-week studies with a 4-week recovery period, and 4-week studies in both species.”
2-week (with 4-week recovery) and 4-week GLP studies in rats and cynomolgus monkeys
“Repeat-dose toxicity in rats and cynomolgus monkeys have been conducted, 2-week studies with a 4-week recovery period, and 4-week studies in both species. The 2-week GLP repeat dose studies incorporated a saline and vehicle control group.”
“Intravenous administration (slow bolus) of remdesivir to rats at dosage levels of ≥3 mg/kg/day for up to 4 weeks resulted in findings indicative of kidney injury and/or dysfunction.”
✓ VerifiedFDA pharmacology/toxicology review, p. 11Source ↗